📈 Stocks · EU

Klaria Pharma Holding AB Stock KLAR · Forecast & Analysis

Stocks EU
News situation · News, 30 days · no price data
▬ Neutral weak Data coverage medium
Price no dataTrend no price dataNews ▬ 5 reports, latest 13.11.

Klaria Pharma Holding AB gets a neutral reading: the rights issue is complete and funding secured, but weak voluntary take-up sends a cautionary signal on demand. How the new cash is used will shape what comes next.

News situation · 5 items / 30 D
▬ Neutral weak Data coverage medium
3.8 Impact / 10
By source type
Release 4 Ad-hoc 1

5 of 5 straight from the issuer or regulator

AI-generated · as of November 13, 2026
News, 30 days
Neutral
Outlook

Outlook for Klaria Pharma Holding AB

Direction, typical moves and upcoming dates from our own price, news and calendar data, recalculated on every visit. An assessment, not investment advice.

News picture · news of the last 30 days only
▬ Neutral weak
Data coverage medium

No price statement: there is no price data for this asset. Based on 5 news items.

What drives it
  • The completed rights issue leaves SEK 73.8m in cash for settling liabilities and the commercial plan.
  • Full exercise of the TO1 warrants could add about SEK 27.8m in further proceeds.
  • Partner CNX Therapeutics' planned European launch in Q4 2026 remains the key commercial catalyst.
What argues against it
  • Only 61.4% of the rights issue was taken up voluntarily, a clear sign of weak shareholder demand.
  • Underwriter Vator had to subscribe SEK 20.5m under its commitment rather than by choice.
  • Shareholders who did not participate face dilution of roughly 43.0%.
What would change the picture
  • A successful European launch by CNX Therapeutics in Q4 2026 would shift attention to execution.
  • Full warrant exercise bringing the extra SEK 27.8m would ease the funding picture further.
Signal history

Both worlds over time

Technical and news signals of the last 90 days on one timeline.

Bullish ▲Bearish ▼10.09. · News signal · Impact 5/1017.09. · News signal · Impact 7/1022.10. · News signal · Impact 3/1022.10. · News signal · Impact 2/1030.10. · News signal · Impact 7/1006.11. · News signal · Impact 2/1013.11. · News signal · Impact 5/10
90 days ago today
Technical signal News signal Size = strength
News, 30 days

What is being reported about KLAR

Frequently asked questions about Klaria Pharma Holding AB

Why does the rights issue outcome leave the picture neutral rather than positive?

The money did come in and the balance sheet gets relief, but only 61.4% was subscribed voluntarily and the underwriter was compelled to take SEK 20.5m. That mix reads as secured funding paired with a demand warning, which is why the verdict stays neutral rather than turning bullish.

What does the roughly 43% dilution mean for existing shareholders?

Shareholders who chose not to subscribe now own a considerably smaller slice of the company, with dilution of about 43.0%. Those who took part or sold their subscription rights softened that effect. The dilution is the price of securing SEK 73.8m in cash for the company's near-term needs.

What should I watch next for KLAR?

Two things: whether the TO1 warrants are exercised in full, which would add roughly SEK 27.8m, and progress at partner CNX Therapeutics ahead of its planned European launch in Q4 2026. There is currently no price history for KLAR, so no technical outlook window can be shown yet.

Asset Snapshot

📝 Overview Generated automatically

KLAR has been the subject of 8 signals across 8 articles in the last 365 days. Sentiment skews Bearish (38%).

Breakdown: 2 bullish, 3 bearish, 3 neutral.

Most-cited catalysts: Q2 revenue guidance cut (1×), Widening user offerings increases expense base (1×), Strategic partnership with Apple to facilitate hardware leasing for iPhones and Apple Watches (1×). Most-cited risk factors: Private company valuation may not correlate with public markets (1×), Guidance cut may be a one-time adjustment (1×), Regulatory scrutiny regarding the impact of BNPL services on consumer debt levels (1×).

Keep exploring

Related assets

Same category or comparable signal picture — each card opens the full cockpit.